Nyxoah SA Net Worth 2021-2026 | NYXH
Interactive chart of historical net worth (market cap) for Nyxoah SA (NYXH) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Nyxoah SA net worth as of September 16, 2026 is $0.06B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.060B | $0.011B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.890B | 42.79 |
| Tempus AI (TEM) | United States | $12.625B | 0.00 |
| 10x Genomics (TXG) | United States | $9.470B | 0.00 |
| Hinge Health (HNGE) | United States | $7.563B | 72.66 |
| Hims & Hers Health (HIMS) | United States | $6.533B | 0.00 |
| Doximity (DOCS) | United States | $4.624B | 28.50 |
| Heartflow (HTFL) | United States | $4.200B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.686B | 243.09 |
| Privia Health (PRVA) | United States | $2.602B | 97.00 |
| Clover Health Investments (CLOV) | United States | $2.422B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.05 |
| Butterfly Network (BFLY) | United States | $1.933B | 0.00 |
| Schrodinger (SDGR) | United States | $1.767B | 0.00 |
| Omnicell (OMCL) | United States | $1.475B | 21.06 |
| Azenta (AZTA) | United States | $1.455B | 79.07 |
| Enovis (ENOV) | United States | $1.076B | 5.57 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.669B | 0.00 |
| Phreesia (PHR) | United States | $0.636B | 34.13 |
| Veradigm (MDRX) | United States | $0.597B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Claritev (CTEV) | United States | $0.569B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.418B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.379B | 0.00 |
| CapsoVision (CV) | United States | $0.300B | 0.00 |
| Standard BioTools (LAB) | United States | $0.278B | 0.00 |
| American Well (AMWL) | United States | $0.221B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.147B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.084B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.063B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.048B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.034B | 0.00 |
| 111 (YI) | China | $0.030B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.019B | 0.00 |
| HeartSciences (HSCS) | United States | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |